A taxonomy of model structures for economic evaluation of health technologies

被引:318
|
作者
Brennan, Alan
Chick, Stephen E.
Davies, Ruth
机构
[1] Univ Sheffield, Sch Hlth & Related Res, Sheffield S14 DA, S Yorkshire, England
[2] INSEAD, Technol & Operat Management Area, Hlth Management Inst, Fontainebleau, France
[3] Univ Warwick, Warwick Business Sch, Coventry, W Midlands, England
关键词
health technology assessment; cost-effectiveness analysis; modelling methodology; simulation; decision tree; Markov model;
D O I
10.1002/hec.1148
中图分类号
F [经济];
学科分类号
02 ;
摘要
Models for the economic evaluation of health technologies provide valuable information to decision makers. The choice of model structure is rarely discussed in published studies and can affect the results produced. Many papers describe good modelling practice, but few describe how to choose from the many types of available models. This paper develops a new taxonomy of model structures. The horizontal axis of the taxonomy describes assumptions about the role of expected values, randomness, the heterogeneity of entities, and the degree of non-Markovian structure. Commonly used aggregate models, including decision trees and Markov models require large population numbers, homogeneous sub-groups and linear interactions. Individual models are more flexible, but may require replications with different random numbers to estimate expected values. The vertical axis of the taxonomy describes potential interactions between the individual actors, as well as how the interactions occur through time. Models using interactions, such as system dynamics, some Markov models, and discrete event simulation are fairly uncommon in the health economics but are necessary for modelling infectious diseases and systems with constrained resources. The paper provides guidance for choosing a model, based on key requirements, including output requirements, the population size, and system complexity. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:1295 / 1310
页数:16
相关论文
共 50 条
  • [1] Health Economics' and the evolution of economic evaluation of health technologies
    Hutton, John
    HEALTH ECONOMICS, 2012, 21 (01) : 13 - 18
  • [2] Economic evaluation of health technologies: challenges and perspectives
    Zerda, Alvaro
    BIOMEDICA, 2014, 34 (02):
  • [3] Spanish recommendations on economic evaluation of health technologies
    Lopez-Bastida, Julio
    Oliva, Juan
    Antonanzas, Fernando
    Garcia-Altes, Anna
    Gisbert, Ramon
    Mar, Javier
    Puig-Junoy, Jaume
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2010, 11 (05): : 513 - 520
  • [4] Spanish recommendations on economic evaluation of health technologies
    Julio López-Bastida
    Juan Oliva
    Fernando Antoñanzas
    Anna García-Altés
    Ramón Gisbert
    Javier Mar
    Jaume Puig-Junoy
    The European Journal of Health Economics, 2010, 11 : 513 - 520
  • [5] A proposed guideline for economic evaluation of health technologies
    Lopez Bastida, Julio
    Oliva, Juan
    Antonanzas, Fernando
    Garcia-Altes, Anna
    Gisbert, Ramon
    Mar, Javier
    Puig-Junoy, Jaume
    GACETA SANITARIA, 2010, 24 (02) : 154 - 170
  • [6] Decision modeling for economic evaluation of health technologies
    de Soarez, Patricia Coelho
    Soares, Marta Oliveira
    Dutilh Novaes, Hillegonda Maria
    CIENCIA & SAUDE COLETIVA, 2014, 19 (10): : 4209 - 4222
  • [7] A Framework for the health economic Evaluation of AAL Technologies
    Mahs, M.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2022, 55 (SUPPL 1): : 111 - 111
  • [8] ECONOMIC-EVALUATION OF HEALTH-CARE TECHNOLOGIES
    JONSSON, B
    ACTA ENDOCRINOLOGICA, 1993, 128 : 50 - 54
  • [9] Issues surrounding the health economic evaluation of genomic technologies
    Buchanan, James
    Wordsworth, Sarah
    Schuh, Anna
    PHARMACOGENOMICS, 2013, 14 (15) : 1833 - 1847
  • [10] The role of pilot studies in the economic evaluation of health technologies
    Drummond, M
    Coyle, D
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1998, 14 (03) : 405 - 418